Conexeu Sciences Inc. (CNXU) vs PDS Biotechnology Corporation (PDSB)
A side-by-side comparison of Conexeu Sciences Inc. and PDS Biotechnology Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CNXU
Conexeu Sciences Inc.
$3.66HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
PDSB
PDS Biotechnology Corporation
$1.05HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CNXU vs PDSB
growth of $100 · dividends reinvested · last 1yCNXU -76.1% (-76.1%/yr)PDSB +20.0% (+20.0%/yr)PDSB compounded faster over this window
Log scale — wide-divergence pair
CNXU PDSB
Metrics side by side
Total return (annualized)
| Metric | CNXU | PDSB |
|---|---|---|
| Total return (1Y) | N/A | 17.56% |
| Total return CAGR (3Y) | N/A | -35.96% |
| Total return CAGR (5Y) | N/A | -39.13% |
| Total return CAGR (10Y) | N/A | -40.75% |
CNXU is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.